Qanaq, Dalal http://orcid.org/0000-0001-5793-6326
O’Keeffe, Majella
Cremona, Simone
Bernardo, Wanderley Marques
McIntyre, Robert D.
Papada, Efstathia
Benkalkar, Saumit
Rubino, Francesco
Article History
Received: 13 May 2023
Revised: 15 March 2024
Accepted: 15 March 2024
First Online: 22 June 2024
Declarations
:
: This article does not contain any studies with human participants or animals performed by any of the authors.
: Informed consent does not apply.
: The principal investigator, Professor Francesco Rubino, reports receiving research funding from Medtronic, Johnson & Johnson, and Novo Nordisk, consulting fees from GI Dynamics and lecturing fees from Johnson & Johnson, Medtronic, and Novo Nordisk. Prof. Rubino also serves on the data safety advisory board of GT Metabolic Solutions and is President of the Metabolic Health Institute (non-profit). All other authors have nothing to disclose.